Company / Return on Equity (ROE)
Neuronetics, Inc. Return on Equity (ROE) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-134.9%
FY2025
5-year range
-134.9% / -54.7%
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Neuronetics, Inc. reports negative total equity of -134.9% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-134.9% in FY2025 with a 5-year CAGR of -101.0%.
Declined from -54.7% to -134.9% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -27.2pp
- 5-Year Change
- -101.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 0.6% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.07 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -134.9% | -0.6% |
| FY2024 | -134.1% | -145.3% |
| FY2023 | -54.7% | +49.2% |
| FY2022 | -107.7% | -77.4% |
| FY2021 | -60.7% | -79.0% |
| FY2020 | -33.9% | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026